Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3201)
All Articles published online
|
Nov 21, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Odes S. How expensive is inflammatory bowel disease? A critical analysis. World J Gastroenterol 2008; 14(43): 6641-6647 [PMID: 19034966 DOI: 10.3748/wjg.14.6641] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i43/6641.htm |
| Number | Citing Articles |
| 1 |
Paweł Kawalec, Krzysztof Piotr Malinowski. Indirect health costs in ulcerative colitis and Crohn’s disease: a systematic review and meta-analysis. Expert Review of Pharmacoeconomics & Outcomes Research 2015; 15(2): 253 doi: 10.1586/14737167.2015.1011130
|
| 2 |
Anne Prenzler, Bernd Bokemeyer, J.-Matthias von der Schulenburg, Thomas Mittendorf. Health care costs and their predictors of inflammatory bowel diseases in Germany. The European Journal of Health Economics 2011; 12(3): 273 doi: 10.1007/s10198-010-0281-z
|
| 3 |
Christian D. Stone. The Economic Burden of Inflammatory Bowel Disease: Clear Problem, Unclear Solution. Digestive Diseases and Sciences 2012; 57(12): 3042 doi: 10.1007/s10620-012-2417-8
|
| 4 |
James Buchanan, Sarah Wordsworth, Tariq Ahmad, Angela Perrin, Severine Vermeire, Miquel Sans, Jenny Taylor, Derek Jewell. Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers. Journal of Crohn's and Colitis 2011; 5(4): 301 doi: 10.1016/j.crohns.2011.02.005
|
| 5 |
Christopher B. Forrest, Wallace V. Crandall, L. Charles Bailey, Peixin Zhang, Marshall M. Joffe, Richard B. Colletti, Jeremy Adler, Howard I. Baron, James Berman, Fernando del Rosario, Andrew B. Grossman, Edward J. Hoffenberg, Esther J. Israel, Sandra C. Kim, Jenifer R. Lightdale, Peter A. Margolis, Keith Marsolo, Devendra I. Mehta, David E. Milov, Ashish S. Patel, Jeanne Tung, Michael D. Kappelman. Effectiveness of Anti-TNFα for Crohn Disease: Research in a Pediatric Learning Health System. Pediatrics 2014; 134(1): 37 doi: 10.1542/peds.2013-4103
|
| 6 |
Orly Sarid, Vered Slonim‐Nevo, Ruslan Sergienko, Avihu Pereg, Elena Chernin, Terri Singer, Dan Greenberg, Doron Schwartz, Hillel Vardi, Michael Friger, Shmuel Odes. Daily hassles score associates with the somatic and psychological health of patients with Crohn's disease. Journal of Clinical Psychology 2018; 74(6): 969 doi: 10.1002/jclp.22561
|
| 7 |
Geoffrey C Nguyen, Thomas A LaVeist, Mary L Harris, Ming-Hsi Wang, Lisa W Datta, Steven R Brant. Racial Disparities in Utilization of Specialist Care and Medications in Inflammatory Bowel Disease. American Journal of Gastroenterology 2010; 105(10): 2202 doi: 10.1038/ajg.2010.202
|
| 8 |
Alberto De Ramón-Fernández, Daniel Ruiz-Fernández, Diego Marcos-Jorquera, Virgilio Gilart-Iglesias, Víctor Vives-Boix. Monitoring-Based Model for Personalizing the Clinical Process of Crohn’s Disease. Sensors 2017; 17(7): 1570 doi: 10.3390/s17071570
|
| 9 |
Byong Duk Ye, Marina Pesegova, Olga Alexeeva, Marina Osipenko, Adi Lahat, Andriy Dorofeyev, Sigal Fishman, Olena Levchenko, Jae Hee Cheon, Maria Lia Scribano, Radu-Bogdan Mateescu, Kang-Moon Lee, Chang Soo Eun, Sang Joon Lee, Sung Young Lee, HoUng Kim, Stefan Schreiber, Heather Fowler, Raymond Cheung, Young-Ho Kim. Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study. The Lancet 2019; 393(10182): 1699 doi: 10.1016/S0140-6736(18)32196-2
|
| 10 |
Dorit Vedel Ankersen, Petra Weimers, Dorte Marker, Charlotte Teglgaard Peters-Lehm, Mette Bennedsen, Malte Rosager Hansen, Jens Olsen, Maria Elmegaard Madsen, Johan Burisch, Pia Munkholm. Costs of electronic health vs. standard care management of inflammatory bowel disease across three years of follow-up–a Danish register-based study. Scandinavian Journal of Gastroenterology 2021; 56(5): 520 doi: 10.1080/00365521.2021.1892176
|
| 11 |
Rasmus Rankala, Juuso Kosonen, Kalle Mattila, Risto Tuominen, Markku Voutilainen, Anssi Mustonen. Direct costs of inflammatory bowel diseases in a Finnish tertiary-level clinic. Frontline Gastroenterology 2021; 12(5): 385 doi: 10.1136/flgastro-2020-101466
|
| 12 |
Kirk K. Lin, Fernando Velayos, Elena Fisher, Jonathan P. Terdiman. Durability of Infliximab Dose Intensification in Crohn’s Disease. Digestive Diseases and Sciences 2012; 57(4): 1013 doi: 10.1007/s10620-011-1969-3
|
| 13 |
Bobby Lo, Ida Vind, Marianne Kajbaek Vester-Andersen, Flemming Bendtsen, Johan Burisch. Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort. Journal of Crohn's and Colitis 2020; 14(1): 53 doi: 10.1093/ecco-jcc/jjz096
|
| 14 |
Johan Burisch, Hillel Vardi, Natalia Pedersen, Marko Brinar, Silvja Cukovic-Cavka, Ioannis Kaimakliotis, Dana Duricova, Martin Bortlik, Olga Shonová, Ida Vind, Søren Avnstrøm, Niels Thorsgaard, Susanne Krabbe, Vibeke Andersen, Jens F. Dahlerup, Jens Kjeldsen, Riina Salupere, Jónger Olsen, Kári R. Nielsen, Pia Manninen, Pekka Collin, Konstantinnos H. Katsanos, Epameinondas V. Tsianos, Karin Ladefoged, Laszlo Lakatos, Yvonne Bailey, Colm OʼMorain, Doron Schwartz, Guido Lupinacci, Angelo De Padova, Laimas Jonaitis, Limas Kupcinskas, Svetlana Turcan, Louisa Barros, Fernando Magro, Daniela Lazar, Adrian Goldis, Inna Nikulina, Elena Belousova, Alberto Fernandez, Juan R. Pineda, Sven Almer, Jonas Halfvarson, Her-Hsin Tsai, Shaji Sebastian, Michael Friger, Dan Greenberg, Peter L. Lakatos, Ebbe Langholz, Selwyn Odes, Pia Munkholm. Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort. Inflammatory Bowel Diseases 2015; 21(1): 121 doi: 10.1097/MIB.0000000000000250
|
| 15 |
Antonio Tursi, Walter Elisei, Marcello Picchio, Antonio Penna, Piera Giuseppina Lecca, Giacomo Forti, GianMarco Giorgetti, Roberto Faggiani, Costantino Zampaletta, Giorgio Pelecca, Giovanni Brandimarte. Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres. European Journal of Internal Medicine 2014; 25(5): 485 doi: 10.1016/j.ejim.2014.02.010
|
| 16 |
Lorraine I. Kelley-Quon, Chi-Hong Tseng, Howard C. Jen, David A. Ziring, Stephen B. Shew. Postoperative complications and health care use in children undergoing surgery for ulcerative colitis. Journal of Pediatric Surgery 2012; 47(11): 2063 doi: 10.1016/j.jpedsurg.2012.07.001
|
| 17 |
Michael Kelso, Rick A Weideman, Daisha J Cipher, Linda A Feagins. Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare. Inflammatory Bowel Diseases 2018; 24(1): 5 doi: 10.1093/ibd/izx020
|
| 18 |
Joana Torres, Silvio Danese, Jean-Frédéric Colombel. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut 2013; 62(11): 1642 doi: 10.1136/gutjnl-2012-303959
|
| 19 |
Alexander Teml, Susanne Karner, Elke Schaeffeler, Matthias Schwab. Pharmacogenetics and Individualized Therapy. 2012; : 323 doi: 10.1002/9781118116494.ch11
|
| 20 |
Danielle Fritze, Weizhen Zhang, Ji-Yao Li, Biaoxin Chai, Michael Mulholland. Thrombin Mediates Vagal Apoptosis and Dysfunction in Inflammatory Bowel Disease. Journal of Gastrointestinal Surgery 2014; 18(8): 1495 doi: 10.1007/s11605-014-2565-6
|
| 21 |
Gert Huppertz-Hauss, Eline Aas, Marte Lie Høivik, Ebbe Langholz, Selwyn Odes, Milada Småstuen, Reinhold Stockbrugger, Geir Hoff, Bjørn Moum, Tomm Bernklev. Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5023973
|
| 22 |
Antonio Di Sabatino, Lucio Liberato, Monia Marchetti, Paolo Biancheri, Gino R. Corazza. Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease. Internal and Emergency Medicine 2011; 6(S1): 17 doi: 10.1007/s11739-011-0673-9
|
| 23 |
Ester Navarro Correal, Olga Benítez Leiva, Angelina Dosal Galguera, Marta Gallego Barrero, Elena Sánchez Pastor, M. Francisca Murciano Gonzalo. Nurse-Led Telephone Advice Line for Patients With Inflammatory Bowel Disease. Gastroenterology Nursing 2019; 42(2): 133 doi: 10.1097/SGA.0000000000000372
|
| 24 |
Sharmila S Prasad, Michael Potter, Simon Keely, Nicholas J Talley, Marjorie M Walker, Therése Kairuz. Roles of healthcare professionals in the management of chronic gastrointestinal diseases with a focus on primary care: A systematic review. JGH Open 2020; 4(2): 221 doi: 10.1002/jgh3.12235
|
| 25 |
Johan Burisch, Hillel Vardi, Doron Schwartz, Michael Friger, Gediminas Kiudelis, Juozas Kupčinskas, Mathurin Fumery, Corinne Gower-Rousseau, Laszlo Lakatos, Peter L Lakatos, Renata D'Incà, Alessandro Sartini, Daniela Valpiani, Martina Giannotta, Naila Arebi, Dana Duricova, Martin Bortlik, Stefania Chetcuti Zammit, Pierre Ellul, Natalia Pedersen, Jens Kjeldsen, Jóngerð Maria Miné Midjord, Kári Rubek Nielsen, Karina Winther Andersen, Vibeke Andersen, Konstantinos H Katsanos, Dimitrios K Christodoulou, Viktor Domislovic, Zeljko Krznaric, Shaji Sebastian, Pia Oksanen, Pekka Collin, Luisa Barros, Fernando Magro, Riina Salupere, Hendrika Adriana Linda Kievit, Adrian Goldis, Ioannis P Kaimakliotis, Jens F Dahlerup, Carl Eriksson, Jonas Halfvarson, Alberto Fernandez, Vicent Hernandez, Svetlana Turcan, Elena Belousova, Ebbe Langholz, Pia Munkholm, Selwyn Odes, Niksa Turk, Silvija Cukovic-Cavka, Anastasia Nicolaou, Milan Lukas, Olga Shonová, Birgitte Blichfeldt, Dorte Marker, Katrine Carlsen, Petra Weimers, Clays Aalykke, Karen Kudsk, Ida Vind, Niels Thorsgaard, Alexandros Skamnelos, Dimitrios Politis, Zsuzsanna Vegh, Peterne Demenyi, Szabina Nemethne Kramli, Giualia Dal Piaz, Alessia Santini, Giulia Girardin, Limas Kupcinskas, Laimas Jonaitis, Irena Valantiene, Romanas Zykus, Ruta Kucinskiene, Daniela Lazar, Inna Nikulina, Luisa de Castro, Juan-Ramon Pineda, Santos Pereira, Jesus Martinez-Cadilla, Luciano Sanroman, Montserrat Figueira, David Martinez Ares, Jose-Ignacio Rodriguez-Prada, Amalia Carmona, Carlos Gonzalez-Portela, Ulla-Britt Widen, Sally Myers, Katherine Ashton, Emma Whitehead. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study. The Lancet Gastroenterology & Hepatology 2020; 5(5): 454 doi: 10.1016/S2468-1253(20)30012-1
|
| 26 |
A. M. Schoepfer, M. Bortolotti, V. Pittet, C. Mottet, J.‐J. Gonvers, O. Reich, N. Fournier, J.‐P. Vader, B. Burnand, P. Michetti, F. Froehlich. The gap between scientific evidence and clinical practice: 5‐aminosalicylates are frequently used for the treatment of Crohn's disease. Alimentary Pharmacology & Therapeutics 2014; 40(8): 930 doi: 10.1111/apt.12929
|
| 27 |
E. J. Mao, G. S. Hazlewood, G. G. Kaplan, L. Peyrin‐Biroulet, A. N. Ananthakrishnan. Systematic review with meta‐analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis. Alimentary Pharmacology & Therapeutics 2017; 45(1): 3 doi: 10.1111/apt.13847
|
| 28 |
Jeannie K. Lee, Derek H. Tang, Lea Mollon, Edward P. Armstrong. Cost-effectiveness of biological agents used in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 2013; 27(6): 949 doi: 10.1016/j.bpg.2013.09.007
|
| 29 |
Reena Khanna, Brian Bressler, Barrett G Levesque, Guangyong Zou, Larry W Stitt, Gordon R Greenberg, Remo Panaccione, Alain Bitton, Pierre Paré, Séverine Vermeire, Geert D'Haens, Donald MacIntosh, William J Sandborn, Allan Donner, Margaret K Vandervoort, Joan C Morris, Brian G Feagan. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial. The Lancet 2015; 386(10006): 1825 doi: 10.1016/S0140-6736(15)00068-9
|
| 30 |
Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi, Rahul Kalla. Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Research 2020; 9: 54 doi: 10.12688/f1000research.20928.1
|
| 31 |
Sandro Ardizzone, Andrea Cassinotti, Roberto de Franchis. Immunosuppressive and biologic therapy for ulcerative colitis. Expert Opinion on Emerging Drugs 2012; 17(4): 449 doi: 10.1517/14728214.2012.744820
|
| 32 |
Caroline Bähler, Stephan R. Vavricka, Alain M. Schoepfer, Beat Brüngger, Oliver Reich. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0681-y
|
| 33 |
Sandra Bohn Thomsen, Kristine Højgaard Allin, Johan Burisch, Camilla Bjørn Jensen, Susanne Hansen, Lise Lotte Gluud, Klaus Theede, Marianne Kiszka‐Kanowitz, Anette Mertz Nielsen, Tine Jess. Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study. United European Gastroenterology Journal 2020; 8(1): 68 doi: 10.1177/2050640619868387
|
| 34 |
J. Hinojosa, J.P. Gisbert, F. Gomollón, A. López San Román. Adherence of gastroenterologists to European Crohn's and Colitis Organisation Consensus on Crohn's disease: A real-life survey in Spain. Journal of Crohn's and Colitis 2012; 6(7): 763 doi: 10.1016/j.crohns.2011.12.013
|
| 35 |
Lily P.H. Yang, Paul L. McCormack. MMX® Mesalazine. Drugs 2011; 71(2): 221 doi: 10.2165/11205870-000000000-00000
|
| 36 |
Mark H. Flasar, Jingdong Chao, A. Burak Ozbay, Martha Skup, Mei Lu, Raymond Cross. Biological and Immunomodulator Use in Crohnʼs Disease in a Medicaid Population. Inflammatory Bowel Diseases 2016; 22(5): 1056 doi: 10.1097/MIB.0000000000000730
|
| 37 |
Ronen Arai. Serologic Markers: Impact on Early Diagnosis and Disease Stratification in Inflammatory Bowel Disease. Postgraduate Medicine 2010; 122(4): 177 doi: 10.3810/pgm.2010.07.2184
|
| 38 |
Uwe Siebert, Johannes Wurm, Raffaella Matteucci Gothe, Marjan Arvandi, Stephan R. Vavricka, Roland von Känel, Stefan Begré, Michael C. Sulz, Christa Meyenberger, Markus Sagmeister. Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2013; 19(4): 847 doi: 10.1097/MIB.0b013e31827f278e
|
| 39 |
Caroline Bähler, Alain M. Schoepfer, Stephan R. Vavricka, Beat Brüngger, Oliver Reich. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland. European Journal of Gastroenterology & Hepatology 2017; 29(8): 916 doi: 10.1097/MEG.0000000000000891
|
| 40 |
Alberto de Ramón-Fernández, Diego Marcos-Jorquera, Antonio Soriano-Payá, Virgilio Gilart-Iglesias, Daniel Ruiz-Fernández, Javier Ramirez-Navarro. Ubiquitous Computing and Ambient Intelligence. Lecture Notes in Computer Science 2016; 10069: 74 doi: 10.1007/978-3-319-48746-5_8
|
| 41 |
A. P. S. Urbano, L. Y. Sassaki, M. S. Dorna, M. A. de Barros Leite Carvalhaes, L. A. Martini, A. L. A. Ferreira. Nutritional intake according to injury extent in ulcerative colitis patients. Journal of Human Nutrition and Dietetics 2013; 26(5): 445 doi: 10.1111/jhn.12064
|
| 42 |
Guozhi Wu, Yuan Yang, Min Liu, Yuping Wang, Qinghong Guo. Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655865
|
| 43 |
João Costa, Fernando Magro, Daniel Caldeira, Joana Alarcão, Rita Sousa, António Vaz-Carneiro. Infliximab Reduces Hospitalizations and Surgery Interventions in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2013; 19(10): 2098 doi: 10.1097/MIB.0b013e31829936c2
|
| 44 |
Ole Haagen Nielsen. New Strategies for Treatment of Inflammatory Bowel Disease. Frontiers in Medicine 2014; 1 doi: 10.3389/fmed.2014.00003
|
| 45 |
Christopher B. Forrest, Peter Margolis, Michael Seid, Richard B. Colletti. PEDSnet: How A Prototype Pediatric Learning Health System Is Being Expanded Into A National Network. Health Affairs 2014; 33(7): 1171 doi: 10.1377/hlthaff.2014.0127
|
| 46 |
Mariabeatrice Principi, Nunzia Labarile, Francesco Paolo Bianchi, Antonella Contaldo, Silvio Tafuri, Enzo Ierardi, Alfredo Di Leo. The Cost of Inflammatory Bowel Disease Management Matches with Clinical Course: A Single Outpatient Centre Analysis. International Journal of Environmental Research and Public Health 2020; 17(12): 4549 doi: 10.3390/ijerph17124549
|
| 47 |
Ashwin N. Ananthakrishnan, Emily L. McGinley, David G. Binion, Kia Saeian. A Nationwide Analysis of Changes in Severity and Outcomes of Inflammatory Bowel Disease Hospitalizations. Journal of Gastrointestinal Surgery 2011; 15(2): 267 doi: 10.1007/s11605-010-1396-3
|